#
##
##
##
Trustee Report
##
##
##
##
##
##
##
##
##
##
##
##
Building Liverpool's
fi'rst cancer hospital
When Clatterbridge Cancer Centre
Liverpool opened in
June 2020, it did so with over £8 million of charitable funding
to support the development of key areas, the purchase of
specialised equipment and the best possible facilities.
Building the safest, cleanest hospital
suddenly taken ill and can be admitted for
possible was particularly important when
immediate care and assessment if needed.
opening during the pandemic, with
This will mean patients can be seen by a
cancer patients being amongst the most
cancer specialist rather than a lengthy wait
vulnerable in the country. This made charity at an A&E and have direct admittance to an
donations more important than ever. Some
inpatient ward if necessary or more likely
areas supported by donations included..
assessed, treated and can then return to
the comfort of their own home.
The Teenage and Young Adult Unit
A therapeutic environment for young
people with eight single en-suite beds in
private rooms, a flexible social space, four
chemotherapy treatment chairs and access
to a rooftop garden terrace.
Bone Marrow Transplant Units
With a particular benefit to blood cancer
patients, these 15 specialist isolation units,
were built with bespoke HEPA-filtered air
flow systems and have at least twelve air
changes per hour, meaning that the air
within the room will provide a protective
environment in regards to filtration and
pressurisation. They also feature an
ante-room to ensure patients in isolation
are protected during their treatment.
Clinical Decision Unit
This innovative department at the hospital
provides a 2417 service for our patients
who become unwell at home. Patients will
be able to call the hotline from their home
anytime during their treatment if they are
ijirl.j
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Page|
|---|---|---|---|
|.|Repoit ofthe Trustees||1to 2|
||Report ofthe Independent
Auditors||3to 4|
||Statement ofFinancial|Activities||
||Balance Sheet|||
||Cash Flow Statement|||
||Notes to the Cash Flow Statement|||
||Notes to the Financial|Statements|9to 19|
||Detailed Statement of|Financial Activities|20|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||31March 2021 31March 2020|31March 2021 31March 2020|
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total funds|Total funds|
||||||fund|funds|||
|||||Notes|f,'000|K'000|f,'000|S'000|
|INCOMING RESOURCES|||||||||
|Incoming resources from|generated||funds||||||
|Voluntary
income|||||1,207|148|1,355|1,481|
|Activities for generating
funds|||||860||860|1,599|
|Investment
income|||||29||29|70|
|Total incoming resources|||||2,096|148|2,244|3,150|
|RESOURCES EXPENDED|||||||||
|Costs ofgenerating
funds|||||||||
|Costs ofgenerating
voluntary||income|||714||714|883|
|Charitable
activities|||||||||
|Patients welfare|||||2,120|959|3,079|7,074|
|Staffwelfare|||||19||19|4|
|Research|||||132||132|127|
|Other|||||63||63|328|
|Governance
costs|||||19||19|15|
|Investment
management|charges||||9||9|9|
|Total resources expended|||||(3,076)|(959)|(4,035)|(8,440)|
|NET INCOMING/(OUTGOING)|||||||||
|RESOURCES|||||(980)|(811)|(1,791)|(5,290)|
|Other recognised
gains/losses|||||||||
|Gains/losses
on investment|assets||||270||270|~129)|
|Net movement
in funds|||||(710)|(811)|(1,521)|(5,419)|
|RECONCILIATION
OF|FUNDS||||||||
|Total funds brought forward|||||1,922|955|2,877|8,296|
|TOTAL FUNDS CARRIED FORWARD|||||1,212|144|1,356|2,877|
##
|Balance Sheet
At 31March 2021||||||
|---|---|---|---|---|---|
|||||31March 2021|31March 2020|
|||Unrestricted|Restricted|Total funds|Total funds|
|||fund|funds|||
||Notes|6000|f,'000||8000|
|FIXEDASSETS||||||
|Investments|10|1,364||1,364|I,lol|
|CURRENT ASSETS||||||
|Debtors||12||12|12|
|Cash at bank||3,140|144|3,284|9,367|
|||3,152|144|3,296|9,379|
|CREDITORS||||||
|Amounts
falling due within one year|12|(3,304)||(3,304)|(7,603)|
|NET CURRENT ASSETS/(LIABILITIES)||~152)|144|(8)|1,776|
|TOTAL ASSETSLESSCURRENT||||||
|LIABILITIES||1,212|144|1,356|2,877|
|NET ASSETS||1,212|144|1,356|2,877|
|FUNDS|13|||||
|Unrestricted
funds||||1,212|1,922|
|Restricted funds||||144|955|
|TOTAL FUNDS||||1,356|2,877|
##
##
|||||||31March 2021|31 March 2020|
|---|---|---|---|---|---|---|---|
||||||Notes|K'000|f,'000|
|Net cash (outflow)/inflow||from operating|activities||1|(6,058)|1,751|
|Returns on investments|and servicing offinance||||2||42|
|Capital expenditure
and||financial investinent|||2|(29)||
|(Decrease)/increase
in cash in the period||||||~6,083)|1,799|
|Reconciliation
ofnet cash||flow to movement||in net||||
|debt||||||||
|(Decrease)/increase
in cash||in the period||||~6,083)|1,799|
|Change in net debt resulting||fiom cash flows||||(60S3)|1,799|
|Movement
in net debt in|the period|||||(6,083)|1,799|
|Net debt at 1April||||||9,367|7,568|
|Net debt at31March||||||3,284|9,367|
##
|OPERATING AC|TIVI|TIES||||
|---|---|---|---|---|---|
|||||31March 2021|31March 2020|
|||||1,9000|f,'000|
|Net outgoing resources||||(1,791)|(5,290)|
|Interest received||||(5)|(36)|
|Online fees and bank charges||||16|19|
|Investment
fees||||9|9|
|Dividends
received||||(24)|(34)|
|Realised gains on sale of||investments||36|1|
|Decrease in debtors|||||18|
|(Decrease)/increase|in creditors|||~4,299|7,064|
|Net cash (outflow)/inflow||from operating|activities|~6,058)|1,751|
##
##
##
|ANALYSIS OF CASH FLO|WS FOR HE|ADIN|GS NETTED IN THE CAS|H FLOW STATEM|ENT|
|---|---|---|---|---|---|
|||||31March 2021|31March 2020|
|||||K'000|X'000|
|Returns on investments
and|servicing offinance|||||
|Interest received||||5|36|
|Online fees and bank charges||||(16)|(19)|
|Investment
fees||||(9)|(9)|
|Dividends
received||||24||
|Net cash inflow for returns|on investments|and|servicing offinance||42|
|Capital expenditure
and financial investment||||||
|Purchase offixed asset investments||||(269)|(77)|
|Sale offixed asset investments||||240|83|
|Net cash (outflow)/inflow
for capital expenditure|||and financial investment|~29)||
|ANALYSIS OF CHANGES|IN NET FUNDS|||||
|ANALYSIS OF CHANGES IN NET FU|NDS|||
|---|---|---|---|
||At 1.4.20|Cash flow|At 31March|
||||2021|
||f,'000|f'000|f'000|
|Net cash||||
|Cash at bank|9,367|(6,0S3)|3,284|
|Total|9,367|L6,0S3)|3,284|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|VOLUNTARY INCOME|||||||||
|---|---|---|---|---|---|---|---|---|
||||31|March|2021|31|March|2020|
||Unrestricted|Restricted|||Total|||Total|
||funds|funds|||funds|||funds|
||F000|6000|||f,'000|||f.'000|
|Donations|531|148|||679|||341|
|Legacies|676||||676|||1,140|
||1,207|148|||1,355|||1,481|
##
|ACTIVITI|ES FOR GENERATI|NG FUNDS||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||31|March|2021|31|March|2020|
|||Unrestricted|Restricted|||Total|||Total|
|||funds|funds|||funds|||funds|
|||f,'000|f'000|||f'000|||f.'000|
|Fundraising|events|860||||860|||1,599|
##
|||||31March 2021|31 March 2020|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||funds|funds|funds|funds|
|||K'000|f,'000|8000|5'000|
|Investments|.|24||24|34|
|Other- bank|interest|5||5|36|
|||29||29|70|
##
|||||31March 2021|31March 2020|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||funds|funds|funds|funds|
|||K'000|f'000|R'000|F000|
|Fundraising|costs|698||698|864|
|Online fees|and bank charges|16||16|19|
|||714||714|883|
##
|CHARITABLE ACTIVITIES|COSTS||||
|---|---|---|---|---|
|Direct costs|||31March 2021|31March 2020|
||Unrestricted|Restricted|Total|Total|
||funds|funds|funds|funds|
||f,'000|f'000|f'000|8000|
|Patients welfare|2,120|959|3,079|7,074|
|Staffwelfare|19||19|4|
|Research|132||132|127|
|Other|63||63|328|
||2,334|959|3,293|7,533|
##
|||||||31|March|2021|31|March|2020|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|||Total|||Total|
|||||funds|funds|||funds|||funds|
|||||f.'000|f.'000|||K'000|||f.'000|
|Auditors'|remuneration|||9||||9|||5|
|Strategic|management|and|governance|10||||10|||10|
|||||19||||19|||15|
##
##
##
##
|STAFF COSTS|||
|---|---|---|
||31March 2021|31March 2020|
||f'000|K'000|
|Salaries and wages|473|474|
|Social security costs|47|46|
|Other pension costs|66|62|
||586|582|
##
|||||Listed|
|---|---|---|---|---|
|||||investments|
|||||F000|
|MARKET VALUE|||||
|At 1 April 2020||||1,101|
|Additions||||269|
|Disposals||||(240)|
|Revaluations||||234|
|At 31March 2021||||1,364|
|NKT BOOKVALUE|||||
|At 31March 2021||||1,364|
|At 31March 2020||||1,101|
||||31March 2021 31March 2020||
||||K'000|8000|
|Historical cost at 31March|||890|871|
|There were no investment|assets outside the UK.||||
|The market value at 31 March:|||||
||||31March 2021 31March 2020||
||||f.'000|.f.'000|
|Investments
listed on Stock Exchange|||1,313|1,080|
|Cash held as part ofthe Investment||Portfolio|51|21|
||||1,364|1,101|
##
##
|DEBTORS: A.M|OUNTS FALLING DUE WIT|HIN ONE YEAR||
|---|---|---|---|
|||31March 2021|31March 2020|
|||f'000|K'000|
|Estate income/gift|aid||4|
|Dividends/interest|||4|
|Other|||4|
|Total||12|12|
##
|CREDITORS|: AMOUNTS FA|LLING DUE WITHIN ONE Y|EAR|||
|---|---|---|---|---|---|
|||||31March 2021|31 March 2020|
|||||f'000|X'000|
|Other creditors||||3,304|7,603|
|MOVEMENT|IN FUNDS|||||
|||||Net||
||||At 1April|movement
in|At 31March|
||||2020|funds|2021|
||||f,'000|F000|F000|
|Unrestricted
funds||||||
|General fund|||1,922|(710)|1,212|
|Restricted funds||||||
|Restricted funds|||955|(811)|144|
|TOTAL FUNDS|||2,877|LI,521)|1,356|
|Net movement|in funds, included|in the above are as follows:||||
|||Incoming|Resources|Gains and|Movement
in|
|||resources|expended|losses|funds|
|||K'000|f'000|f'000|f'000|
|Unrestricted
funds||||||
|General
fund||2,096|(3,076)|270|(710)|
|Restricted funds||||||
|Restricted
funds||148|(959)||(811)|
|TOTAL FUNDS||2,244|(4,035)|270|(1,521)|
##
##
##
|Comparatives|for movement
in funds||||
|---|---|---|---|---|
||||Net||
|||At 1April|movement
in|At 31March|
|||2019|funds|2020|
|||f,'000|f'000|6000|
|Unrestricted|Funds||||
|General fund||7,472|(5,550)|1,922|
|Restricted Funds|||||
|Restricted
funds||824|131|955|
|TOTAL FUNDS||8,296|(5,419)|2,877|
||Incoming|Resources|Gains and|Movement
in|
|---|---|---|---|---|
||resources|expended|losses|funds|
||f.'000|f'000|f.'000|K'000|
|Unrestricted
funds|||||
|General fund|3,01S|(8,439)|(129)|(5,550)|
|Restricted funds|||||
|Restricted
funds|132|||131|
|TOTAL FUNDS|3,150|~8,440)|(129)|(5,419)|
##
##
|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||8000|f,)000|f'000|
|Fixed assets||1,101||1,101|
|Current assets
Creditors||8,424
~7,603)|955|9,379
~7,603)|
|Total||1,922|955|2,877|
|Restricted funds|||||
||||31March|31 March|
||||2021|2020|
|Macmillan
Nurses|based at CCC||8,075|8,075|
|Gifts for Children|||1,351|1,351|
|Thermoplastics|||6,250|6,250|
|Wigs|||1,000|7,000|
|Work in Southport|Area||1,000|1,000|
|Pancreatic Cancer|Research||75|75|
|TCC - Chemo at Home||||24,348|
|Mattresses|||6,500|6,500|
|TCC - Chemo Chair||||20,000|
|TCC - Relatives Room||||277,000|
|Bluebell Study|||6,000|6,000|
|TCC - Therapy Room||||115,000|
|TCC - Transplant|Suite|||150,000|
|Inpatient
Bedroom||||5,000|
|Teenage Unit||||30,000|
|Dementia Clocks|||460|460|
|TYA Interactive TV||||5,000|
|Sefton Residents
Only|||359|359|
|Fluroscopy
Machine||||25,000|
|TCC - Clinical Decisions Unit||||200,000|
|Christmas
Decorations||||742|
|TCC Rooftop Tenace Level 6||||40,000|
|TCC Emma Rodgers Sculpture||||25,000|
|Staff|||383|383|
|COVID 19Staffand patients|||113,015||
||||144,468|954,544|
##
##
##
||||||||||31March|31March|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2021|2020|
||||||||||f.'000|8000|
|705|To support|the services|provided|by CCC|NHS FT||||181|625|
|701|To support|the services|provided|by CCC|NHS FT||||35|292|
|702|To provide|equipment|within
the|Diagnostic Imaging||Department|||10|10|
||To support|in-patient
services, particularly|||those provided||within Mersey||||
|709|Ward|||||||||8|
|710|To support|the services|provided|by CCC|NHS FT|||||10|
|712|To support|the services|provided|by CCC|NHS FT|||||6|
|712|To provide|equipment|within the|Diagnostic Imaging||Department||||8|
||To support|in-patient
services, particularly|||those provided||within Mersey||||
|720|Ward||||||||||
||To support|in-patient
services, particularly|||those provided||within Conway||||
|722|Ward||||||||||
||To support|Cancer Research, particularly|||Breast Cancer, within CCC NHS||||||
|724|FT||||||||40|41|
|725|To support|Radiographers
Training
within|||CCC NHS|FT|||9|10|
|739|To support|Cancer Research within CCC|||NHS FT||||44|46|
|740|To support|Cancer Research, particularly|||Brain Cancer, within CCC NHS FT||||20|21|
|743|To support|Radiotherapy
Services and Research within CCC||||||NHS FT|46|48|
|747|To support|the services|provided|by CCC|NHS FT||||31|32|
||To support|Radiotherapy
Services and Research, particularly||||||Proton Therapy,|||
|748|within CCCNHS FT||||||||1|1|
|752|To support|the services|provided|by CCC|NHS FT||||27|27|
|754|To support|the services|provided|by CCC|NHS FT||||7|7|
|755|To support|the services|provided|by CCC|NHS FT|||||235|
|756|To support|the services|provided|by CCC|NHS FT||||12|13|
||Unrealised|Gains/(loss)|on investments||||||702|468|
||||||||||1,212|1,922|
##
||||2020/21|2019/20|
|---|---|---|---|---|
||||f!000|f.'000|
|CCC Fundraising
Costs (including||salaries)|745|899|
|Contribution|to Patients Welfare||3,072|7,074|
|Contribution|to Staff Welfare|||2|
|Contribution|to Research and Development||131|120|
|Contribution|to Other Salaries||||
|Contribution|to Capital||||
|Governance|Costs||10|10|
|Miscellaneous|||21|280|
|Total|||3,979|8,385|
##
##
##
|Detailed Statement ofFinancial|Detailed Statement ofFinancial|Detailed Statement ofFinancial|Activities|||
|---|---|---|---|---|---|
|for the Year Ended 31March 2021||||||
|||||31March 2021|31 March 2020|
|||||f.'000|f'000|
|INCOMING RESOURCES||||||
|Voluntary
income||||||
|Donations||||679|341|
|Legacies||||676|1,140|
|||||1,355|1,481|
|Activities for generating||funds||||
|Fundraising
events||||860|1,599|
|Investment
income||||||
|Investments||||24|34|
|Other- bank interest||||5|36|
|||||29|70|
|Total incoming resources||||2,244|3,150|
|RESOURCES EXPENDED||||||
|Costs ofgenerating|voluntary||income|||
|Fundraising
costs||||698|864|
|Online fees and bank|charges|||16|19|
|||||(714)|(883)|
|Charitable
activities||||||
|Patient welfare||||3,079|7,074|
|Staffwelfare||||19|.4|
|Research||||132|127|
|Other||||63|328|
|||||(3,293)|(7,533)|
|Governance
costs||||||
|Auditors'
remuneration||||9|5|
|Strategic management|and|governance||10|10|
|||||(19)|(15)|
|Investment
management||charges||||
|Charges payable||||(9)||
|Total resources expended||||(4,035)|(8,440)|
|Net expenditure||||(1,791)|(5,290)|
##
##
##
##